Company record
Teva Pharmaceuticals USA, Inc
0 FDA warning letters since 2023 and 17 recalls in the last 12 months.
Get an email the day FDA posts anything new about Teva Pharmaceuticals USA, Inc.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 21 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05 Presence of Foreign Tablets/Capsules |
| Sep 9 | Class II | Teva Pharmaceuticals USA, Inc Drug |
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01 Presence of Foreign Tablets/Capsules |
| May 13 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled syringe containing 2 mL of diluent, one vial adapter, and one … Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. |
| Apr 29 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx… Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc… CGMP Deviations: use of an unapproved raw material |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc… CGMP Deviations: use of an unapproved raw material |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc… CGMP Deviations: use of an unapproved raw material |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack). Superpotent and Subpotent |
| Apr 15 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). Superpotent and Subpotent |
| Apr 1 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For:… Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. |
| Apr 1 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For:… Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. |
| Apr 1 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL vial in Kit, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For:… Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. |
| Mar 11 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054 Failed Dissolution Specifications |
| Mar 11 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Metoprolol Succinate Extended-Release Tablets, 25 mg, 100 tablets bottles (NDC: 45963-709-11) and 1,000 tablets bottles (NDC: 45963-709-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054 Failed Dissolution Specifications |
| Mar 11 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11 Failed Dissolution Specifications |
| Mar 11 | Class II | Teva Pharmaceuticals USA, Inc Drug |
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054. Failed Dissolution Specifications |
| Dec 10, 2025 | Class III | Teva Pharmaceuticals USA, Inc Drug |
Carton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, Manufactured by: Actavis Laboratories, Inc, Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc., Parsippany, NJ … Defective Container - A defect in the side-seal which allows leakage of product. |